Syneos Health and Elligo Health Research are entering a strategic collaboration to mobilize a system of accelerated research to reach real-world patients. 
 
Applying its Goes Direct^® approach, Elligo identifies patients for clinical trials using electronic health records and then provides their physicians with the infrastructure to conduct the research in their own practices. This platform enables research at practices that historically would not have had the infrastructure to conduct clinical research. Syneos Health will collaborate with Elligo to pilot new ways of quickly finding patients to enlist them in clinical trial research.
 
The collaboration will seek to build a centrally managed infrastructure and regulatory research system around physicians and patients who have not typically been accessible in traditional sites. This could include deploying expert staff and providing the training and regulatory guidance needed to run a trial, removing physician burden and focusing the experience around the patient.
 
“Our biopharma acceleration model is designed to completely surround the patient, caregiver or any stakeholder with the most relevant solutions to make the clinical trial process easier and more accessible. Our collaboration with Elligo allows us to do just that,” said Alistair Macdonald, chief executive officer, Syneos Health. “By leveraging data, technology and trusted physician relationships, we believe we can radically reduce enrollment times and impact health outcomes on behalf of our customers.”
 
“We are thrilled to collaborate with Syneos Health to create a system of accelerated research that expands our vision of engaging the patient and physician in clinical research,” said John Potthoff, Ph.D., chief executive officer, Elligo. “Not only are we maximizing clinical trial process efficiencies, we’re transforming the clinical trial paradigm with deeper insights and more actionable real-world evidence.”